Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.08)
%-2.81
Latest2.77
High2.84
Low2.76
Volume135,172
Turnover (SEK)378,074
Market Cap (MSEK)148

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:29 PMAVAAVA2.77500
5:05 PMNONAVA2.76991
5:05 PMAVAAVA2.761,000
5:05 PMAVAAVA2.766,000
5:05 PMAVAAVA2.76230
5:05 PMAVAAVA2.76300
5:01 PMAVAAVA2.791,200
4:56 PMAVAAVA2.794,000
4:29 PMAVAAVA2.79400
4:26 PMAVAAVA2.80100

Scheduled Reports

DateReport
2017-11-10Extra bolagsstämma
2017-11-18Delårsrapport ett
2017-12-14Årsstämma




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se